The Food and Drug Administration signed a memorandum of understanding with a Russian institute
In the presence of His Royal Highness Prince Abdulaziz bin Salman bin Abdulaziz, Minister of Energy, the Saudi Food and Drug Authority (SFDA) took a new strategic step towards strengthening international cooperation in the health and pharmaceutical sector by signing a memorandum of understanding with the State Institute of Pharmaceuticals and Good Practices in the Russian Federation. This significant signing took place on the sidelines of the 29th St. Petersburg International Economic Forum, held in St. Petersburg, Russia, reflecting the depth of the growing bilateral relations between the Kingdom of Saudi Arabia and the Russian Federation in various vital fields.
The importance of the role of food and drugs in promoting joint pharmaceutical oversight
The Saudi Food and Drug Authority (SFDA) was represented at the signing of this agreement by its Executive Vice President for Operations, Mr. Sami Al-Saqr, while the Russian side was represented by the Director of the State Institute for Pharmaceutical Products and Good Practices, Mr. Vladislav Shestakov. This joint cooperation aims to establish a practical framework for the exchange of knowledge and technical expertise, and to develop human resources in the fields of drug control and pharmaceutical inspection, thereby ensuring the application of the highest quality and safety standards for pharmaceutical products circulating in both countries.
Dimensions of strategic partnership and its impact on the pharmaceutical sector
This agreement comes at a historical juncture marked by a significant growth in economic and technological relations between Riyadh and Moscow. Saudi Arabia, through its Vision 2030, is striving to localize pharmaceutical industries and achieve national drug security, while Russia possesses advanced infrastructure and extensive expertise in medical research and biopharmaceuticals. The integration of these efforts through this memorandum of understanding will facilitate drug registration procedures and the mutual recognition of Good Manufacturing Practices (GMP), opening new horizons for trade and investment in the pharmaceutical sector at both the regional and international levels.
Objectives of the Memorandum of Understanding and Areas of Technical Cooperation
The memorandum focuses primarily on strengthening joint coordination and exchanging expertise on regulations and technical systems related to good manufacturing practices. Areas of cooperation also include developing quality management systems for pharmaceutical inspection and training specialized national personnel to enhance their regulatory capabilities. Furthermore, the two parties will work to exchange best regulatory and supervisory practices related to pharmaceutical products, ensuring the protection of public health and the provision of safe and effective medical products to consumers in both countries.
St. Petersburg International Economic Forum as a platform for international cooperation
The St. Petersburg International Economic Forum is one of the world's leading economic platforms, bringing together annually world leaders, government officials, policymakers, and representatives of major global companies to discuss current economic challenges and shape future international cooperation. This year's forum is being held under the theme "Pragmatic Dialogue: The Path to a Stable Future," which perfectly reflects the nature of the partnership between the Saudi Food and Drug and its Russian counterpart. This partnership is based on achieving shared interests and promoting health and economic stability through practical and well-considered steps.
